•
Jun 30, 2016

Outlook Therapeutics Q3 2016 Earnings Report

Total Revenue
$495K
Previous year: $1.29M
-61.8%
EPS
-$35.8
Previous year: -$121
-70.3%
Gross Profit
$0
0
Cash and Equivalents
$13.6M
Total Assets
$33M

Outlook Therapeutics

Outlook Therapeutics